Author response for 'Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trials'

Authors :: William H. Polonsky
Robert Silver
Jonas Håkan-Bloch
Sayeh Tadayon
Johan Jendle
Troels Krarup Hansen
Kari Uusinarkaus
Melanie J. Davies
Andreas L. Birkenfeld
Publication Year :: 2019
Publisher :: Wiley, 2019.

Subjects :: Treatment satisfaction
medicine.medical_specialty
business.industry
Semaglutide
Internal medicine
medicine
Once weekly
In patient
Type 2 diabetes
medicine.disease
business

Full Text Access

Tools